Livial: an economic appraisal.
Phillips
C J
CJ
School of Health Science, University of Wales, Swansea.
D045930:Anabolic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D020249:Hormone Replacement Therapy / Q000191:economics*; D006801:Humans; D009652:Norpregnenes / Q000191:economics* / Q000627:therapeutic use; D011788:Quality of Life; D019057:Quality-Adjusted Life Years
D045930:Anabolic Agents; D009652:Norpregnenes; C027385:tibolone